KalVista wants to raise $160M; Prime Medicine's upsized offering; Applied Tx's PhIII data
Plus, news about Intellia and ReCode:
KalVista aims to raise $160M following pivotal readout: Earlier this week, the company said its oral …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
